Skip to main content

Table 3 Differences between the last 7 days on treatment and the run-out period stratified by genotype for subjects previously treated with FSC

From: Effect of β2 -adrenergic receptor gene Arg16Gly polymorphisms on response to long-acting β2-agonist in Chinese Han asthmatic patients

 

Genotype

 

Arg/Arg(n = 21)

Arg/Gly(n = 26)

Gly/Gly(n = 15)

Morning PEF (L/min)

−38.2 ± 8.6

−24.2 ± 10.2

−34.3 ± 9.8

FEV1 (L)

−0.09 ± 0.05

−0.10 ± 0.03

−0.10 ± 0.03

Total albuterol use

0.71 ± 0.23

0.69 ± 0.38

0.73 ± 0.28

Asthma symptom score

0.43 ± 0.17

0.35 ± 0.19

0.33 ± 0.14

  1. No significant difference.